Cyclin Dependent Kinase Inhibitor 1A (CDKN1A) Antibody

Product Graph
260€ (50 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Cyclin Dependent Kinase Inhibitor 1A (CDKN1A) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx210510
tested applications
ELISA, IHC

Description

CDKN1A Antibody is a Rabbit Polyclonal against CDKN1A.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Cyclin Dependent Kinase Inhibitor 1A (CDKN1A)
Host
Rabbit
Reactivity
Human
Recommended Dilution
ELISA: 1/2000 - 1/5000, IHC: 1/25 - 1/100. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Antigen Affinity Chromatography.
Size 1
50 µl
Size 2
100 µl
Form
Liquid
Tested Applications
ELISA, IHC
Buffer
PBS, pH 7.4, containing 0.05% NaN3 and 40% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P38936
Gene ID
1026
Background
Antibody anti-CDKN1A
Status
RUO

Descripción

Related Products

EH14267

Human CDKN1A (Cyclin-dependent kinase inhibitor 1) ELISA Kit

Ver Producto
ER0822

Rat CDKN1A (Cyclin Dependent Kinase Inhibitor 1A) ELISA Kit

Ver Producto
FNab06067

CDKN1A antibody

CDKN1A(p21, CIP1, WAF1) is a cyclin-dependent kinase inhibitor. CDKN1A binds to and inhibits the activity of cyclin-CDK2 or-CDK4 complexes, and thus functions as a regulator of cell cycle progression at the G1 phase. The expression of CDKN1A is induced by wild-type but not mutant p53 protein, through which CDKN1A mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. CDKN1A can interact with proliferating cell nuclear antigen(PCNA), and plays a regulatory role in S phase DNA replication and DNA damage repair. CDKN1A was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of CDK2, and may be instrumental in the execution of apoptosis following caspase activation. Two alternatively spliced variants, which encode an identical protein, have been reported.

Ver Producto